FDA's 21st Century Cures Plan Gives Patient-Focused Drug Development A Boost
US agency will hold five workshops and develop seven guidance documents focused on patient input in the drug development and review process; since some guidance requirements under Cures law overlap with those in PDUFA VI commitment letter, most of the funding will come from user fees.
